Pharmacopeia
CWP-0246
SUGAMMADEX
Neuromuscular · Neuromuscular · Level 2
Core pharmacology
- Class Group
Neuromuscular - Miscellaneous
- Legacy Cicm Level
Level 3
- Introduction
Cyclodextrin Selective Relaxant Binding Agent
- Indications Uses
1. Reversal of NMB by aminosteroid NMBA (Rocuronium>vecuronium>>pancuronium)
- Presentation
Clear colourless or pale yellow solution for injection
Contains 100mg/ml of y-Cyclodextrin Sugammadex- Mechanism of action
Encapsulates steroid portion of aminosteroid molecules. The binding leads to a decrease of free drug in the central compartment, leading to a diffusion gradient away from the NMJ.
Median time to recovery 90 seconds- Adverse Effects Toxicity
1. Anaphylaxis
2. Fluclox can displace aminosteroids from Sugammadex- Protein binding
Not protein bound
- Metabolism
None
- Excretion
95% unaltered in urine
- Half-life
T1/2 is 1.8 hours
- Route And Dose
4mg/kg for deep block
2mg/kg for shallow block
16mg/kg for rescue reversal in RSI CICO scenario